newsfilter
← Latest News
Business Wire·

Forma Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on May 6, 2022

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today announced that it will release first quarter 2022 financia